Global Cell Line Development Market Outlook 2031: Increasing Risk of Pandemics and Communicable Diseases Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 27, 2022--

The "Global Cell Line Development Market Outlook 2031" report has been added to ResearchAndMarkets.com's offering.

The global cell line development market is anticipated to grow with a CAGR of 12.39% over the forecast period, i.e., 2022 - 2031. Factors such has growing burden of cancer, and rising need for vaccine production to drive the market growth in the coming years. Additionally, the rising burden of osteoporosis, and also growing risk of coronavirus are expected to boost the market growth. The market estimated to generate revenue of USD 14,600 Million by the end of 2031, up from a revenue of USD 4,500 Million in the year 2021.

The global cell line development market is segmented into numerous segments which include segmentation by product, cell type, application, and by industry. By cell type, the market is segmented into CHO cells, BHK 21 cells, NSO cells, and more. Out of which, BHK 21 cells is anticipated to garner a revenue of USD 2,400 Million by the end of 2031, up from a revenue of USD 700 Million in the year 2021. Furthermore the CHO cells segment is expected to garner the largest revenue of USD 5,400 Million by the end of 2031.

On the basis of region, the global cell line development market is divided into five key regions which includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Out of which, the Asia Pacific market is anticipated to generate revenue USD 3,900 Million. A total of $1,100 million was made by the Asia Pacific market in 2021. Additionally, by the end of 2031, the North American market is anticipated to generate USD 5,100 Million in the most revenue.

Market Dynamics

Drivers

• Increasing Demand for Monoclonal Antibodies

Challenges

• Development of a Stable and Authentic Cell Lines

Trends

• Cell Line Development Based on Mammalian Cells

Opportunities

• Increasing Risk of Pandemics and Communicable Disease

Key Topics Covered:

1. Market Definition and Research Methodology

2. Executive Summary - Global Cell Line Development Market

3. Industry Value Chain Analysis

4. Market Dynamics

5. Regulatory and Standards Landscape

6. Industry Risk Analysis in Cell Line Development Workflow Environment

7. Trends in Cell Line Development

8. Process Technology Workflow

9. Impact of COVID-19 on Global Cell Line Development Market

10. Workflow Timeline Analysis

11. Cell Isolation Technology

12. Technology Type for Gene Transfer in Cell Isolation Workflow

13. Challenges in Cell Line Development Workflow Environment

14. Competitive Landscape

15. Global Cell Line Development Market 2021-2031

16. North America Cell Line Development Market 2021-2031

17. Europe Cell Line Development Market 2021-2031

18. Asia Pacific Cell Line Development Market 2021-2031

19. Latin America Cell Line Development Market 2021-2031

20. Middle East & Africa Cell Line Development Market 2021-2031

21. Analyst Recommendation based on

Companies Mentioned

• Lonza Group Ltd.
• Thermo Fisher Scientific
• Corning Incorporated
• General Electric Company
• Sartorius AG
• Selexis SA
• Merck KGaA
• WuXi AppTec
• American Type Culture Collection (ATCC)
• European Collection of Authentic Cell Cultures.

For more information about this report visit https://www.researchandmarkets.com/r/7rv1zi

View source version on businesswire.com:https://www.businesswire.com/news/home/20221027005621/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENETICS HEALTH STEM CELLS

SOURCE: Research and Markets

Copyright Business Wire 2022.